Researchers publishing in Oxford University Press have uncovered significant inconsistencies regarding vaping's effectiveness as a smoking cessation tool. By analyzing 38 studies derived from a national U.S. database, investigators found that e-cigarettes may be far less effective for smokers actively attempting to quit than previously assumed.
Cigarette smoking remains the world's leading cause of preventable death. In the U.S. alone, 28.8 million adults smoked in 2022. While 67.7% expressed a desire to quit and over half made an attempt, only 8.8% were successful. Despite the availability of FDA-approved medications, usage remains low, leading many to turn to Nicotine Vape Products (NVPs).
Vaping prevalence has surged since 2010, with about 6% of adults using devices in 2022. Because most users are current or former smokers, vapes are widely viewed as a harm-reduction alternative. However, controversy persists over their actual efficacy.
To address conflicting data, researchers conducted a narrative review of 38 studies that all utilized the Population Assessment of Tobacco and Health (PATH) Study. They extracted key study characteristics to understand why results varied so wildly. The review yielded four critical findings:
- Mixed Success Rates: Overall, 63.2% of the studies reported that vaping increased the odds of quitting cigarettes within one to three years.
- The Benchmark Issue: In several studies, vaping did not appear beneficial simply because it was compared against established FDA-approved treatments, where it failed to demonstrate superior results.
- Daily vs. Occasional Use: Daily vaping proved to be a significantly stronger predictor of successful cessation compared to intermittent or occasional use.
- The Role of Quit Intention: Studies that included all participants regardless of their desire to quit reported an 85% positive association. However, in studies strictly limited to smokers actively attempting to quit, that positive association plummeted to just 35.3%.
"Regarding the association between vape products and smoking cessation, researchers are advised against making broad claims based on any single study in general," stated lead author Shu Xu. Xu emphasized the necessity of carefully examining multiple studies using the same data source to accurately assess the consistency of findings.
- The paper, "Effectiveness of Nicotine Vape Products (E-cigarettes) as a Smoking Cessation Aid for US Adults - A Narrative Review of Findings from the Population Assessment of Tobacco and Health Study," is available (at midnight on April 30th) at https://doi.org/10.1093/ntr/ntag068 .
Vape Lifestyle & Advocacy Blogger
Chloe Evans, widely known as "CloudChaser Chloe," is a prominent voice in the global vaping community, celebrated for her vibrant personality and keen focus on the lifestyle aspects of vaping. Based in the creative hub of Portland, Oregon, Chloe's content blends fashion, art, and harm reduction, offering a fresh perspective on the vaping world. She aims to demystify vaping for adult consumers and challenge outdated perceptions, promoting a responsible and enjoyable experience.